1. Melanoma metastases caught in the AKT. (3rd March 2016) Authors: Kircher, David A.; Arave, Rowan A.; Cho, Joseph H.; Holmen, Sheri L. Journal: Molecular & cellular oncology Issue: Volume 3:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Model‐dependent outcomes: Sex as a biological variable in preclinical mouse models of melanoma. (11th November 2020) Authors: Parkman, Gennie L.; Kircher, David A.; Stehn, Christopher M.; McMahon, Martin; Holmen, Sheri L. Journal: Pigment cell & melanoma research Issue: Volume 34:Number 3(2021) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Resistance mechanisms to genetic suppression of mutant NRAS in melanoma. Issue 6 (December 2017) Authors: Robinson, James P.; Rebecca, Vito W.; Kircher, David A.; Silvis, Mark R.; Smalley, Inna; Gibney, Geoffrey T.; Lastwika, Kristin J.; Chen, Guo; Davies, Michael A.; Grossman, Douglas; Smalley, Keiran S.M.; Holmen, Sheri L.; VanBrocklin, Matthew W. Journal: Melanoma research Issue: Volume 27:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The role of PI3'‐lipid signalling in melanoma initiation, progression and maintenance. Issue 1 (9th November 2021) Authors: Parkman, Gennie L.; Foth, Mona; Kircher, David A.; Holmen, Sheri L.; McMahon, Martin Other Names: Haass Nikolas guestEditor.; Bedogni Barbara guestEditor. Journal: Experimental dermatology Issue: Volume 31:Issue 1(2022) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗